|
1
|
Lawrence T, Willoughby DA and Gilroy DW:
Anti-inflammatory lipid mediators and insights into the resolution
of inflammation. Nat Rev Immunol. 2:787–795. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davies NM, Reynolds JK, Undeberg MR, Gates
BJ, Ohgami Y and Vega-Villa KR: Minimizing risks of NSAIDs:
Cardiovascular, gastrointestinal and renal. Expert Rev Neurother.
6:1643–1655. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kyriakopoulos AM, Nagl M, Baliou S and
Zoumpourlis V: Alleviating promotion of inflammation and cancer
induced by nonsteroidal anti-inflammatory drugs. Int J Inflam.
2017:96320182017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hardy RS, Raza K and Cooper MS:
Therapeutic glucocorticoids: Mechanisms of actions in rheumatic
diseases. Nat Rev Rheumatol. 16:133–144. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crane E and List A: Immunomodulatory
drugs. Cancer Invest. 23:625–634. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qandil AM: Prodrugs of nonsteroidal
anti-inflammatory drugs (NSAIDs), more than meets the eye: A
critical review. Int J Mol Sci. 13:17244–17274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vane JR and Botting RM: Mechanism of
action of nonsteroidal anti-inflammatory drugs. Am J Med.
104:2S–8S; discussion 21S-22S. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ericson-Neilsen W and Kaye AD: Steroids:
Pharmacology, complications, and practice delivery issues. Ochsner
J. 14:203–207. 2014.PubMed/NCBI
|
|
9
|
Bascones-Martinez A, Mattila R, Gomez-Font
R and Meurman JH: Immunomodulatory drugs: Oral and systemic adverse
effects. Med Oral Patol Oral Cir Bucal. 19:e24–e31. 2014.
View Article : Google Scholar :
|
|
10
|
Leon R, Wu H, Jin Y, Wei J, Buddhala C,
Prentice H and Wu JY: Protective function of taurine in
glutamate-induced apoptosis in cultured neurons. J Neurosci Res.
87:1185–1194. 2009. View Article : Google Scholar
|
|
11
|
Chang CY, Shen CY, Kang CK, Sher YP, Sheu
WH, Chang CC and Lee TH: Taurine protects HK-2 cells from oxidized
LDL-induced cytotoxicity via the ROS-mediated mitochondrial and
p53-related apoptotic pathways. Toxicol Appl Pharmacol.
279:351–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schaffer S, Azuma J, Takahashi K and
Mozaffari M: Why is taurine cytoprotective? Adv Exp Med Biol.
526:307–321. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baliou S, Kyriakopoulos AM, Spandidos DA
and Zoumpourlis V: Role of taurine, its haloamines and its lncRNA
TUG1 in both inflammation and cancer progression. On the road to
therapeutics? (Review). Int J Oncol. 57:631–664. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakajima Y, Osuka K, Seki Y, Gupta RC,
Hara M, Takayasu M and Wakabayashi T: Taurine reduces inflammatory
responses after spinal cord injury. J Neurotrauma. 27:403–410.
2010. View Article : Google Scholar
|
|
15
|
Zhang F, Mao Y, Qiao H, Jiang H, Zhao H,
Chen X, Tong L and Sun X: Protective effects of taurine against
endotoxin-induced acute liver injury after hepatic ischemia
reperfusion. Amino Acids. 38:237–245. 2010. View Article : Google Scholar
|
|
16
|
Bhavsar TM, Cantor JO, Patel SN and
Lau-Cam CA: Attenuating effect of taurine on
lipopolysaccharide-induced acute lung injury in hamsters. Pharmacol
Res. 60:418–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdih H, Kelly CJ, Bouchier-Hayes D, Barry
M and Kearns S: Taurine prevents interleukin-2-induced acute lung
injury in rats. Eur Surg Res. 32:347–352. 2000. View Article : Google Scholar
|
|
18
|
Sun M, Zhao Y, Gu Y and Xu C:
Anti-inflammatory mechanism of taurine against ischemic stroke is
related to down-regulation of PARP and NF-κB. Amino Acids.
42:1735–1747. 2012. View Article : Google Scholar
|
|
19
|
Son MW, Ko JI, Doh HM, Kim WB, Park TS,
Shim MJ and Kim BK: Protective effect of taurine on TNBS-induced
inflammatory bowel disease in rats. Arch Pharm Res. 21:531–536.
1998. View Article : Google Scholar
|
|
20
|
Shimizu M, Zhao Z, Ishimoto Y and Satsu H:
Dietary taurine attenuates dextran sulfate sodium (DSS)-induced
experimental colitis in mice. Adv Exp Med Biol. 643:265–271. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Z, Satsu H, Fujisawa M, Hori M,
Ishimoto Y, Totsuka M, Nambu A, Kakuta S, Ozaki H and Shimizu M:
Attenuation by dietary taurine of dextran sulfate sodium-induced
colitis in mice and of THP-1-induced damage to intestinal Caco-2
cell monolayers. Amino Acids. 35:217–224. 2008. View Article : Google Scholar
|
|
22
|
Son M, Kim HK, Kim WB, Yang J and Kim BK:
Protective effect of taurine on indomethacin-induced gastric
mucosal injury. Adv Exp Med Biol. 403:147–155. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Redmond HP, Stapleton PP, Neary P and
Bouchier-Hayes D: Immunonutrition: The role of taurine. Nutrition.
14:599–604. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klebanoff SJ: Myeloperoxidase: Friend and
foe. J Leukoc Biol. 77:598–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weiss SJ, Klein R, Slivka A and Wei M:
Chlorination of taurine by human neutrophils. Evidence for
hypochlorous acid generation. J Clin Invest. 70:598–607. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marcinkiewicz J and Kontny E: Taurine and
inflammatory diseases. Amino Acids. 46:7–20. 2014. View Article : Google Scholar :
|
|
27
|
Marcinkiewicz J, Grabowska A, Bereta J and
Stelmaszynska T: Taurine chloramine, a product of activated
neutrophils, inhibits in vitro the generation of nitric oxide and
other macrophage inflammatory mediators. J Leukoc Biol. 58:667–674.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marcinkiewicz J, Mak M, Bobek M, Biedroń
R, Białecka A, Koprowski M, Kontny E and Maśliński W: Is there a
role of taurine bromamine in inflammation? Interactive effects with
nitrite and hydrogen peroxide. Inflamm Res. 54:42–49. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim C, Park E, Quinn MR and Schuller-Levis
G: The production of superoxide anion and nitric oxide by cultured
murine leukocytes and the accumulation of TNF-alpha in the
conditioned media is inhibited by taurine chloramine.
Immunopharmacology. 34:89–95. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim C and Cha YN: Production of reactive
oxygen and nitrogen species in phagocytes is regulated by taurine
chloramine. Adv Exp Med Biol. 643:463–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Park E, Quinn MR, Wright CE and
Schuller-Levis G: Taurine chloramine inhibits the synthesis of
nitric oxide and the release of tumor necrosis factor in activated
RAW 264.7 cells. J Leukoc Biol. 54:119–124. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olszanecki R, Kurnyta M, Biedroń R,
Chorobik P, Bereta M and Marcinkiewicz J: The role of heme
oxygenase-1 in down regulation of PGE2 production by taurine
chloramine and taurine bromamine in J774.2 macrophages. Amino
Acids. 35:359–364. 2008. View Article : Google Scholar
|
|
33
|
Kontny E, Chorąży-Massalska M, Rudnicka W,
Marcinkiewicz J and Maśliński W: Comparison of taurine chloramine
and taurine bromamine effects on rheumatoid arthritis synoviocytes.
Amino Acids. 32:447–452. 2007. View Article : Google Scholar
|
|
34
|
Marcinkiewicz J, Wojas-Pelc A, Walczewska
M, Lipko-Godlewska S, Jachowicz R, Maciejewska A, Białecka A and
Kasprowicz A: Topical taurine bromamine, a new candidate in the
treatment of moderate inflammatory acne vulgaris: A pilot study.
Eur J Dermatol. 18:433–439. 2008.PubMed/NCBI
|
|
35
|
Kyriakopoulos A, Logotheti S,
Marcinkiewicz J and Nagl M: N-chlorotaurine and N-bromotaurine
combination regimen for the cure of Valacyclovir-unresponsive
Herpes Zoster Comorbidity in a multiple Sclerosis patient. Int J
Med Pharm Case Rep. 7:1–6. 2016. View Article : Google Scholar
|
|
36
|
Pasich E, Walczewska M, Białecka A, Peruń
A, Kasprowicz A and Marcinkiewicz J: Taurine haloamines and
biofilm: II. Efficacy of taurine bromamine and chlorhexidine
against selected microorganisms of oral biofilm. Adv Exp Med Biol.
803:133–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martini C, Hammerer-Lercher A, Zuck M,
Jekle A, Debabov D, Anderson M and Nagl M: Antimicrobial and
anticoagulant activities of N-Chlorotaurine, N,
N-Dichloro-2,2-dimethyltaurine, and
N-monochloro-2,2-Dimethyltaurine in human blood. Antimicrob Agents
Chemother. 56:1979–1984. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Walczewska M, Peruń A, Białecka A, Śróttek
M, Jamróz W, Dorożyński P, Jachowicz R, Kulinowski P, Nagl M,
Gottardi W and Marcinkiewicz J: Comparative analysis of
microbicidal and anti-inflammatory properties of novel taurine
bromamine derivatives and bromamine T. Adv Exp Med Biol. 975(Pt 1):
515–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nair CG, Lalithakumari R and Senan PI:
Bromamine-T as a new oxidimetric titrant. Talanta. 25:525–527.
1978. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Baliou S, Goulielmaki M, Ioannou P,
Cheimonidi C, Trougakos IP, Nagl M, Kyriakopoulos AM and
Zoumpourlis V: Bromamine T (BAT) exerts stronger anti-cancer
properties than taurine (Tau). Cancers (Basel). 13:1822021.
View Article : Google Scholar
|
|
41
|
Kyriakopoulos AM, Nagl M, Orth-Höller D,
Marcinkiewicz J, Baliou S and Zoumbourlis V: Successful treatment
of a unique chronic multi-bacterial scalp infection with
N-chlorotaurine, N-bromotaurine and bromamine T. Access Microbiol.
2:acmi0001262020. View Article : Google Scholar :
|
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
43
|
Sedgwick AD, Sin YM, Edwards JC and
Willoughby DA: Increased inflammatory reactivity in newly formed
lining tissue. J Pathol. 141:483–495. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang Z, Zhao C, Chen Y, Cowell JA, Wei G,
Kultti A, Huang L, Thompson CB, Rosengren S, Frost GI and Shepard
HM: Recombinant human hyaluronidase PH20 does not stimulate an
acute inflammatory response and inhibits lipopolysaccharide-induced
neutrophil recruitment in the air pouch model of inflammation. J
Immunol. 192:5285–5295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Akbar M, Fraser AR, Graham GJ, Brewer JM
and Grant MH: Acute inflammatory response to cobalt chromium
orthopaedic wear debris in a rodent air-pouch model. J R Soc
Interface. 9:2109–2119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Eteraf-Oskouei T, Mikaily Mirak S and
Najafi M: Anti-inflammatory and anti-angiogenesis effects of
verapamil on rat air pouch inflammation model. Adv Pharm Bull.
7:585–591. 2017. View Article : Google Scholar
|
|
47
|
Li B, Hu Y, Zhao Y, Cheng M, Qin H, Cheng
T, Wang Q, Peng X and Zhang X: Curcumin attenuates titanium
particle-induced inflammation by regulating macrophage polarization
in vitro and in vivo. Front Immunol. 8:552017.
|
|
48
|
Calil IL, Zarpelon AC, Guerrero AT,
Alves-Filho JC, Ferreira SH, Cunha FQ, Cunha TM and Verri WA Jr:
Lipopolysaccharide induces inflammatory hyperalgesia triggering a
TLR4/MyD88-dependent cytokine cascade in the mice paw. PLoS One.
9:e900132014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sartori T, Galvão dos Santos G,
Nogueira-Pedro A, Makiyama E, Rogero MM, Borelli P and Fock RA:
Effects of glutamine, taurine and their association on inflammatory
pathway markers in macrophages. Inflammopharmacology. 26:829–838.
2018. View Article : Google Scholar
|
|
50
|
Chesney RW: Taurine: Its biological role
and clinical implications. Adv Pediatr. 32:1–42. 1985.PubMed/NCBI
|
|
51
|
Duarte DB, Vasko MR and Fehrenbacher JC:
Models of inflammation: Carrageenan air pouch. Curr Protoc
Pharmacol. 72:5.6.1–5.6.9. 2016. View Article : Google Scholar
|
|
52
|
Zhang Y, Zhou X and Zhou B: DC-derived
TSLP promotes Th2 polarization in LPS-primed allergic airway
inflammation. Eur J Immunol. 42:1735–1743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Segawa R, Mizuno N, Hatayama T, Jiangxu D,
Hiratsuka M, Endo Y and Hirasawa N: Lipopolysaccharide-activated
leukocytes enhance thymic stromal lymphopoietin production in a
mouse air-pouch-type inflammation model. Inflammation.
39:1527–1537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen YS, Lin HH, Liu PJ, Tsai HY, Hsueh
PT, Liu HY and Chen YL: Use of 3-hydroxy fatty acid concentrations
in a murine air pouch infection model as a surrogate marker for LPS
activity: A feasibility study using environmental Burkholderia
cenocepacia isolates. J Microbiol Methods. 87:368–374. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vassalli P: The pathophysiology of tumor
necrosis factors. Annu Rev Immunol. 10:411–452. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Germano G, Allavena P and Mantovani A:
Cytokines as a key component of cancer-related inflammation.
Cytokine. 43:374–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Apostolaki M, Armaka M, Victoratos P and
Kollias G: Cellular mechanisms of TNF function in models of
inflammation and autoimmunity. Curr Dir Autoimmun. 11:1–26. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Vasigar P and Batmanabane M:
Anti-inflammatoryactivity of calciumchannel blocker lercanidipine
hydrochloride. J Pharmacol Pharmacother. 4:238–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang XD, Zhao SY, Li YL, Zhu DL, Zhang R,
Sheng JJ and Wang SJ: Taurine affects expression of ICAM-1, VCAM-1
by p38 pathway in hypoxic endothelial cells. Zhongguo Zhong Yao Za
Zhi. 42:2350–2354. 2017.PubMed/NCBI
|
|
60
|
Ulrich-Merzenich G, Zeitler H, Vetter H
and Bhonde RR: Protective effects of taurine on endothelial cells
impaired by high glucose and oxidized low density lipoproteins. Eur
J Nutr. 46:431–438. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ozawa T, Koyama K, Ando T, Ohnuma Y,
Hatsushika K, Ohba T, Sugiyama H, Hamada Y, Ogawa H, Okumura K and
Nakao A: Thymic stromal lymphopoietin secretion of synovial
fibroblasts is positively and negatively regulated by Toll-like
receptors/nuclear factor-kappaB pathway and
interferon-gamma/dexamethasone. Mod Rheumatol. 17:459–463. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zenobia C and Hajishengallis G: Basic
biology and role of interleukin-17 in immunity and inflammation.
Periodontol 2000. 69:142–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Eskan MA, Jotwani R, Abe T, Chmelar J, Lim
JH, Liang S, Ciero PA, Krauss JL, Li F, Rauner M, et al: The
leukocyte integrin antagonist Del-1 inhibits IL-17-mediated
inflammatory bone loss. Nat Immunol. 13:465–473. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Li L, Huang L, Vergis AL, Ye H, Bajwa A,
Narayan V, Strieter RM, Rosin DL and Okusa MD: IL-17 produced by
neutrophils regulates IFN-gamma-mediated neutrophil migration in
mouse kidney ischemia-reperfusion injury. J Clin Invest.
120:331–342. 2010. View Article : Google Scholar
|
